Newsroom > Articles

# Events
2023.11

Medexprim is set to showcase its cutting-edge, regulatory-grade multi-imaging and multimodal datasets at RSNA 2023 in Chicago. These datasets will play a pivotal role in advancing medical diagnostics and treatment planning. By encompassing the entire spectrum of imaging data integral to the patient treatment journey, Medexprim positions itself as a comprehensive solution provider capable of addressing a wide array of pathologies dependent on various imaging modalities. From radiology and radiotherapy to nuclear medicine, genomics, and digital pathology, the company’s offerings span the breadth of medical imaging, empowering healthcare professionals and researchers with robust and reliable data for informed decision-making.

Join us at booth #4365.

Schedule a meeting

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

IQVIA clôture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spécialiste mondial d’analyses avancées, de solutions technologiques et de services de recherche clinique…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation

Medexprim is set to showcase its cutting-edge, regulatory-grade multi-imaging and multimodal datasets at RSNA…

ESMO Congress 2023, D-1 / Medexprim spearheads Real-World Data to…

Medexprim, a leading innovator in the field of Real-World Data and healthcare solutions, is…